This company has shut down. Spotlight Therapeutics is no longer operating — its last tracked round was a Series B in 2022.
Explore the Startup GraveyardSpotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
Spotlight Therapeutics has raised $36.5M in total funding. The most recent round was Series B. The last funding was announced in March 2022.
Spotlight Therapeutics's investors include Google Ventures, Emerson Collective, DNA Capital, EPIQ Capital Group, Team Builder Ventures.
Spotlight Therapeutics is headquartered in Hayward, United States.
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
Spotlight Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spotlight Therapeutics — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/spotlight-therapeutics. Accessed October 17, 2026.
VCBacked. (2022). Spotlight Therapeutics — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/spotlight-therapeutics
{{cite web |title=Spotlight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spotlight-therapeutics |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated